Older studies describing cyclin D1-negative MCL, confirmed by gene expression signature, and demonstrating cyclin D2 or D3 overexpression but lacking demonstrable rearrangement by conventional break-apart probes, possibly represented such cases (49). This evidence concerns the gene CCND2 and mantle cell lymphoma.